QTNT QUOTIENT LTD

Quotient Limited Announces Proposed Amendments to Senior Secured Notes

Quotient Limited Announces Proposed Amendments to Senior Secured Notes

Improved debt terms reduces $93 million principal amortization payments over next 36 months

JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced that in connection with the public offering announced today, the Company has agreed with the beneficial owners of all $132.9 aggregate principal amount of its 12% Senior Secured Notes due 2025 (the SSNs) to amend the indenture governing the SSNs to:

  • Reduce expected amortization payments by $93 million over the next 36 months, by replacing the current amortization schedule (requiring semi-annual amortization payments beginning April 2023 ranging from $12.1 million to $24.2 million) with a schedule requiring quarterly payments of $2.5 million beginning in July 2024 and ending in July 2025, with the remaining principal balance due in October 2025; and
  • Make various other changes, including the addition of a provision requiring that 40% of the net cash proceed from any sale of the Company's Alba business will be applied to repay SSNs and specifying that the Company can use the balance of the proceeds to fund operating expenses, capital expenditures and other investments permitted by the indenture.

The Company has agreed that the holders of the SSNs will be entitled to appoint an observer to the Company's board of directors. In consideration of the SSN holders' consent to the amendments referred to above, the Company has agreed to issue to those holders warrants exercisable for 5% of the aggregate amount of the Company's ordinary shares that are issued and outstanding immediately after completion of the public offering. The exercise price for the warrants will be the greater of (i) $0.75 per share or (ii) 150% of the price at which ordinary shares are offered to the public in the offering.

The effectiveness of the amendments of the Senior Secured Notes described above is conditioned on the Company's raising gross cash proceeds of not less than $15 million in the public offering and any other offering of ordinary shares completed on or prior to July 15, 2022.

About Quotient Limited

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that it believes reshape the way diagnostics are practiced. The MosaiQ solution, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ solution is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Switzerland, Scotland, US and the UAE.

The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

Forward Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include statements regarding the proposed underwritten public offering, including the anticipated offering size. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including: market conditions; Quotient's ability to satisfy closing conditions related to the proposed offering; and other risks set forth in Quotient's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, as well as other documents that Quotient files with the Securities and Exchange Commission, including the Registration Statement on Form S-3 (File No. 333-248235), as amended by Amendment No. 1, for the offering. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Quotient disclaims any obligation to update these forward-looking statements because of new information, future events or circumstances or other factors. The Quotient logo, Quotient MosaiQ and MosaiQ are trademarks or registered trademarks of Quotient Limited or its subsidiaries in various jurisdictions.

CONTACT: Investor Relations, ; 6



EN
23/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on QUOTIENT LTD

 PRESS RELEASE

Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq ...

Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order to implement the delisting, the Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") on or about December 27, 2022. The delisting of the Company's ordinary shares will take effec...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: November 2, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Quotient Limited Announces Reverse Stock Split Effective Today

Quotient Limited Announces Reverse Stock Split Effective Today JERSEY, Channel Islands, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that a reverse split of its ordinary shares, nil par value ("Ordinary Shares"), at a ratio of 1-for-40 became effective following close of trading on the Nasdaq Global Market today. The Company's Ordinary Shares will begin trading on a split-adjusted basis when the market opens on November 3, 2022 under the existing trading symbol, "QTNT." The reverse stock split i...

 PRESS RELEASE

Quotient Limited Announces Intent to Effect Reverse Stock Split

Quotient Limited Announces Intent to Effect Reverse Stock Split JERSEY, Channel Islands, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that it will effect a one-for-40 reverse stock split ("Reverse Stock Split") of its ordinary shares, nil par value ("Ordinary Shares") that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market ("Nasdaq"). The Company's Ordinary Shares are expected to begin trading on a split-adjusted basis when ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: September 17, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch